Revenue figures are a critical indicator of a company's financial performance. Immunocore's lower-than-expected revenue could lead to a negative perception among investors, potentially causing a short-term decline in the stock price. The confidence in this analysis is high due to the direct correlation between earnings reports and stock performance, although market conditions and other factors could also influence the stock's movement.